The Food & Drug Administration (FDA) has released its findings after reviewing a decade of studies, saying it has not found no proof of a link between cell phones and cancer.
The FDA analyzed “peer-reviewed in vivo (animal) and epidemiological studies published from January 1, 2008 to August 1, 2018 for in vivo studies, and from January 1, 2008 to May 8, 2018 for epidemiological studies.” The goal was to determine what, if any, effect radiofrequency radiation (RFR) had on human beings and whether it was responsible for an increased risk of cancer.
The FDA said there were approximately 125 articles considered most relevant to the analysis, none of which adequately demonstrated a link between the level of cell phone RFR and health risks. In fact, the reports says that “based on the FDA’s ongoing evaluation, the available epidemiological and cancer incidence data continues to support the Agency’s determination that there are no quantifiable adverse health effects in humans caused by exposures at or under the current cell phone exposure limits.”
In spite of what seems to be good news, the FDA does express concern that small subsets of the population who are already predisposed toward developing tumors may be at a greater risk and suffer more harm from RFR than the general population. The FDA recommends studies shift toward those population subsets.
In the meantime, the report summarizes its conclusions by stating: “Existing epidemiological evidence indicates that if any risk does exist, it is extremely low compared to both the natural incidence of the disease and known controllable risk factors. As further research is conducted, we will continue to monitor the available information.”